BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17462692)

  • 1. Myristoylation signal transfer from the large to the middle or the small HBV envelope protein leads to a loss of HDV particles infectivity.
    Abou-Jaoudé G; Molina S; Maurel P; Sureau C
    Virology; 2007 Aug; 365(1):204-9. PubMed ID: 17462692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the antigenic loop of the hepatitis B virus envelope proteins in infectivity of hepatitis delta virus.
    Jaoudé GA; Sureau C
    J Virol; 2005 Aug; 79(16):10460-6. PubMed ID: 16051838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the large hepatitis B virus envelope protein in infectivity of the hepatitis delta virion.
    Sureau C; Guerra B; Lanford RE
    J Virol; 1993 Jan; 67(1):366-72. PubMed ID: 8416375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a hepatitis B and hepatitis delta virus receptor binding site.
    Engelke M; Mills K; Seitz S; Simon P; Gripon P; Schnölzer M; Urban S
    Hepatology; 2006 Apr; 43(4):750-60. PubMed ID: 16557545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the cytosolic domains of the hepatitis B virus envelope proteins for their function in viral particle assembly and infectivity.
    Blanchet M; Sureau C
    J Virol; 2006 Dec; 80(24):11935-45. PubMed ID: 17020942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Entry of hepatitis delta virus requires the conserved cysteine residues of the hepatitis B virus envelope protein antigenic loop and is blocked by inhibitors of thiol-disulfide exchange.
    Abou-Jaoudé G; Sureau C
    J Virol; 2007 Dec; 81(23):13057-66. PubMed ID: 17898062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infectivity determinants of the hepatitis B virus pre-S domain are confined to the N-terminal 75 amino acid residues.
    Blanchet M; Sureau C
    J Virol; 2007 Jun; 81(11):5841-9. PubMed ID: 17376925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity.
    Gripon P; Le Seyec J; Rumin S; Guguen-Guillouzo C
    Virology; 1995 Nov; 213(2):292-9. PubMed ID: 7491754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis D and B virus genotypes in chronically infected patients from the Eastern Amazon Basin.
    Gomes-Gouvêa MS; Pereira Soares Mdo C; Guedes de Carvalho Mello IM; Brito EM; Pereira Moia Lde J; Bensabath G; Nunes HM; Carrilho FJ; Pinho JR
    Acta Trop; 2008 Jun; 106(3):149-55. PubMed ID: 18420172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two potentially important elements of the hepatitis B virus large envelope protein are dispensable for the infectivity of hepatitis delta virus.
    Gudima S; Meier A; Dunbrack R; Taylor J; Bruss V
    J Virol; 2007 Apr; 81(8):4343-7. PubMed ID: 17251287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of N glycosylation of hepatitis B virus envelope proteins in morphogenesis and infectivity of hepatitis delta virus.
    Sureau C; Fournier-Wirth C; Maurel P
    J Virol; 2003 May; 77(9):5519-23. PubMed ID: 12692255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-linked glycosylation of hepatitis B surface antigens is involved but not essential in the assembly of hepatitis delta virus.
    Wang CJ; Sung SY; Chen DS; Chen PJ
    Virology; 1996 Jun; 220(1):28-36. PubMed ID: 8659125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis delta virus.
    Taylor JM
    Virology; 2006 Jan; 344(1):71-6. PubMed ID: 16364738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Support of the infectivity of hepatitis delta virus particles by the envelope proteins of different genotypes of hepatitis B virus.
    Freitas N; Abe K; Cunha C; Menne S; Gudima SO
    J Virol; 2014 Jun; 88(11):6255-67. PubMed ID: 24648462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies to inhibit entry of HBV and HDV into hepatocytes.
    Urban S; Bartenschlager R; Kubitz R; Zoulim F
    Gastroenterology; 2014 Jul; 147(1):48-64. PubMed ID: 24768844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro characterization of viral fitness of therapy-resistant hepatitis B variants.
    Villet S; Billioud G; Pichoud C; Lucifora J; Hantz O; Sureau C; Dény P; Zoulim F
    Gastroenterology; 2009 Jan; 136(1):168-176.e2. PubMed ID: 18996386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myristylation of the large surface protein is required for hepatitis B virus in vitro infectivity.
    Bruss V; Hagelstein J; Gerhardt E; Galle PR
    Virology; 1996 Apr; 218(2):396-9. PubMed ID: 8610467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine mapping of pre-S sequence requirements for hepatitis B virus large envelope protein-mediated receptor interaction.
    Schulze A; Schieck A; Ni Y; Mier W; Urban S
    J Virol; 2010 Feb; 84(4):1989-2000. PubMed ID: 20007265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hepatitis B virus-infected cells with alpha-glucosidase inhibitors results in production of virions with altered molecular composition and infectivity.
    Lazar C; Durantel D; Macovei A; Zitzmann N; Zoulim F; Dwek RA; Branza-Nichita N
    Antiviral Res; 2007 Oct; 76(1):30-7. PubMed ID: 17548120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on relationship between hepatitis B virus DNA load and genotype with large envelope protein].
    Rao GF; Chen EF; Yan MH; Zheng MQ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Oct; 22(5):348-50. PubMed ID: 19469171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.